|
home / accelerate drug development
 Accelerate drug development
Target validation
High-throughput protein analysis can radically reduce the cycle time and cost of
biomarker discovery, drug development, and disease
diagnostics. Intrinsic Bioprobes, Inc. (IBI) offers superior industrial-scale protein analysis services for
investigating any protein detectable in human biological fluids. IBI can help your organization reveal protein
variants related to specific diseases or that may be created during
the administration ofldrugs.
IBI applies its unparalleled expertise in human protein analysis through proven, cost-effective, proprietary
tools and processes.
  Learn more about biomarker discovery with IBI >>
Personalized Medicine
Individualized medicine leads to more effective therapies and reduces the risk of adverse therapy responses. Identifying patient characteristics associated with a disease, screening a population for these biomarkers, and assessing responses to therapy are all required to bring targeted therapies into reality. High-throughput protein analysis by IBI is the most cost-effective, data-rich, and accurate means available of finding new biomarkers, identifying known biomarkers in biological media, and assessing therapies during clinical trials.
Learn more about Population Proteomics™ with IBI >>
Clinical Trial Acceleration
Proteins in biological fluids provide specific information about the presence of disease and patient responses to therapy. Because genes express themselves through proteins, the same information sought from genetics can often be found faster and in more detail by analyzing proteins directly. When genetic correlations are important, it is still faster and more cost-effective to use IBI’s protein analysis services to select individuals for gene sequencing than it is to sequence an entire cohort of therapeutic candidates.
Learn more about pharmacokinetics with IBI >>
| 
